Role of GLI2 in the growth of human osteosarcoma

Journal of Pathology

Volumn 224, Issue 2, 2011, Pages 169-179

  Nagao, Hiroko ^a   Ijiri, Kosei ^a   Hirotsu, Masataka ^a   Ishidou, Yasuhiro ^a   Yamamoto, Takuya ^a   Nagano, Satoshi ^a   Takizawa, Takumi ^b   Nakashima, Kinichi ^b   Komiya, Setsuro ^a   Setoguchi, Takao ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

cell cycle; GLI2; Hedgehog; osteosarcoma

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR GLI2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

ANIMALS; BONE NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE KNOCKDOWN TECHNIQUES; HEDGEHOG PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; OSTEOSARCOMA; PYRIDINES; PYRIMIDINES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 79955821961     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2880     Document Type: Article

References (53)

1. Sweetnam R,. Osteosarcoma. Br J Hosp Med 1982; 28: 112,116-121.
2. Dorfman HD, Czerniak B,. Bone cancers. Cancer 1995; 75: 203-210.
3. Wu PK, Chen WM, Chen CF, et al., Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients. Japan J Clin Oncol 2009; 39: 514-522.
4. Iwamoto Y, Tanaka K, Isu K, et al., Multi-institutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J. J Orthop Sci 2009; 14: 397-404.
5. Meyers PA, Schwartz CL, Krailo M, et al., Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005; 23: 2004-2011. (Pubitemid 46211380)
6. Kager L, Zoubek A, Kastner U, et al., Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 2006; 24: 1535-1541. (Pubitemid 46638775)
7. Horowitz JM, Park SH, Bogenmann E, et al., Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 1990; 87: 2775-2779.
8. Ingham PW, McMahon AP,. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001; 15: 3059-3087. (Pubitemid 33115673)
9. Ruiz i Altaba A, Sanchez P, Dahmane N,. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev 2002; 2: 361-372. (Pubitemid 37328949)
10. Lum L, Beachy PA,. The Hedgehog response network: sensors, switches, and routers. Science (NY) 2004; 304: 1755-1759. (Pubitemid 38787882)
11. Bijlsma MF, Spek CA, Peppelenbosch MP,. Hedgehog: an unusual signal transducer. Bioessays 2004; 26: 387-394. (Pubitemid 38461619)
12. Ding Q, Motoyama J, Gasca S, et al., Diminished sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. Development (Camb UK) 1998; 125: 2533-2543. (Pubitemid 28396152)
13. Ruiz i Altaba A, Mas C, Stecca B,. The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol 2007; 17: 438-447. (Pubitemid 47505310)
14. Nakahara H, Misawa H, Hayashi T, et al., Bone repair by transplantation of hTERT-immortalized human mesenchymal stem cells in mice. Transplantation 2009; 88: 346-353.
15. Hijioka H, Setoguchi T, Miyawaki A, et al., Up-regulation of Notch pathway molecules in oral squamous cell carcinoma. Int J Oncol 2010; 36: 817-822.
16. Hirotsu M, Setoguchi T, Matsunoshita Y, et al., Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells. Br J Cancer 2009; 101: 2030-2037.
17. Sasaki H, Hui C, Nakafuku M, et al., A binding site for Gli proteins is essential for HNF-3β floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development (Camb, UK) 1997; 124: 1313-1322. (Pubitemid 27190104)
18. Sasaki H, Nishizaki Y, Hui C, et al., Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development (Camb, UK) 1999; 126: 3915-3924. (Pubitemid 29440488)
19. Fukushima M, Setoguchi T, Komiya S, et al., Retinal astrocyte differentiation mediated by leukemia inhibitory factor in cooperation with bone morphogenetic protein 2. Int J Dev Neurosci 2009; 27: 685-690.
20. Sasaki H, Setoguchi T, Matsunoshita Y, et al., The knock-down of over-expressed EZH2 and BMI-1 does not prevent osteosarcoma growth. Oncology Rep 2010; 23: 677-684.
21. Hirotsu M, Setoguchi T, Sasaki H, et al., Smoothened as a new therapeutic target for human osteosarcoma. Mol Cancer 2010; 9: 5.
22. Lauth M, Bergstrom A, Shimokawa T, et al., Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 2007; 104: 8455-8460. (Pubitemid 47175509)
23. Tang N, Song WX, Luo J, et al., Osteosarcoma development and stem cell differentiation. Clin Orthop Rel Res 2008; 466: 2114-2130.
24. Roessler E, Ermilov AN, Grange DK, et al., A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. Hum Mol Genet 2005; 14: 2181-2188. (Pubitemid 41418017)
25. Elbashir SM, Harborth J, Lendeckel W, et al., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498. (Pubitemid 32494397)
26. Davis ME, Zuckerman JE, Choi CH, et al., Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010; 464: 1067-1070.
27. Desch P, Asslaber D, Kern D, et al., Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene 2010; 29: 4885-4895.
28. Gimenez S, Costa C, Espinet B, et al., Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas. Exp Dermatol 2005; 14: 883-890. (Pubitemid 41723205)
29. Fishman A, Shalom-Paz E, Fejgin M, et al., Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization. Int J Gynecol Cancer 2005; 15: 261-266. (Pubitemid 40396962)
30. Liu XP, Sato T, Oga A, et al., Two subtypes of mucinous colorectal carcinoma characterized by laser scanning cytometry and comparative genomic hybridization. Int J Oncol 2004; 25: 615-621.
31. Wreesmann VB, Ghossein RA, Hezel M, et al., Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 2004; 40: 355-364. (Pubitemid 38902548)
32. Wei G, Lonardo F, Ueda T, et al., CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer 1999; 80: 199-204.
33. 1 phase. Nat Cell Biol 2004; 6: 1229-1235. (Pubitemid 39625122)
34. 1 phase of the cell cycle. Mol Cell Biol 2005; 25: 9292-9303. (Pubitemid 41507831)
35. Rubin LL, de Sauvage FJ,. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006; 5: 1026-1033. (Pubitemid 44835129)
36. Ross J, Li L,. Recent advances in understanding extrinsic control of hematopoietic stem cell fate. Curr Opin Hematol 2006; 13: 237-242. (Pubitemid 44288899)
37. Tanaka M, Setoguchi T, Hirotsu M, et al., Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br J Cancer 2009; 100: 1957-1965.
38. Tian H, Callahan CA, DuPree KJ, et al., Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA 2009; 106: 4254-4259.
39. Yauch RL, Gould SE, Scales SJ, et al., A paracrine requirement for hedgehog signalling in cancer. Nature 2008; 455: 406-410.
40. Sanchez P, Hernandez AM, Stecca B, et al., Inhibition of prostate cancer proliferation by interference with sonic hedgehog-GLI1 signaling. Proc Natl Acad Sci USA 2004; 101: 12561-12566. (Pubitemid 39122063)
41. Singh RR, Cho-Vega JH, Davuluri Y, et al., Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res 2009; 69: 2550-2558.
42. Lindemann RK,. Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma. Cancer Res 2008; 68: 961-964. (Pubitemid 351272211)
43. Wong SY, Seol AD, So PL, et al., Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 2009; 15: 1055-1061.
44. Dierks C, Beigi R, Guo GR, et al., Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 2008; 14: 238-249.
45. Clarke MF, Fuller M,. Stem cells and cancer: two faces of Eve. Cell 2006; 124: 1111-1115.
46. Murase M, Kano M, Tsukahara T, et al., Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer 2009; 101: 1425-1432.
47. Beachy PA, Karhadkar SS, Berman DM,. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324-331. (Pubitemid 39551660)
48. Dierks C, Grbic J, Zirlik K, et al., Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 2007; 13: 944-951. (Pubitemid 47222041)
49. Zhao C, Chen A, Jamieson CH, et al., Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458: 776-779.
50. Ginestier C, Hur MH, Charafe-Jauffret E, et al., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567. (Pubitemid 350056407)
51. Huang EH, Hynes MJ, Zhang T, et al., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-3389.
52. Cheung AM, Wan TS, Leung JC, et al., Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 2007; 21: 1423-1430. (Pubitemid 46965282)
53. Wang L, Park P, Zhang H, et al., Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer 2011; 128: 294-303.